Virtual Medicinal Product (VMP)
-
Brivaracetam 50mg/5ml solution for injection vials
Name Details
|
Current Name
Brivaracetam 50mg/5ml solution for injection vials
|
Start Date
28-01-2016
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intravenous, solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N03AX23
| BNF |
|
Current BNF
04080100
|
Start Date
04-04-2022
|
End Date
|
|
Previous BNF
04080100
|
Start Date
04-01-2017
|
End Date
03-04-2022
|
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 31534411000001107 |
28-01-2016 |
|
VMP Ingredients
VMP ingredients table
| Brivaracetam |
Based on Ingredient Substance |
|
10 mg |
1 ml |
Name
Brivaracetam
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTM
Brivaracetam
-
VMP
(Current) Brivaracetam 50mg/5ml solution for i...
Virtual Medicinal Product Pack (VMPP) Information